Does Wellbutrin (bupropion) XL 300mg decrease the effect of Tetrahydrocannabinol (THC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin XL 300mg Does Not Decrease the Effect of THC

Wellbutrin XL (bupropion) 300mg does not decrease the effects of THC, and may potentially enhance certain effects of THC through drug interactions. 1, 2

Mechanism of Interaction Between Bupropion and THC

  • Bupropion functions primarily as a weak inhibitor of dopamine and noradrenaline reuptake, as well as an antagonist of nicotinic acetylcholine receptors 3
  • THC is a cannabinoid receptor Type 1 (CB1) and cannabinoid receptor Type 2 (CB2) partial agonist that affects multiple organ systems including the central nervous system, cardiovascular system, and respiratory system 1
  • THC metabolites can competitively inhibit several major hepatic cytochrome P450 enzymes, including CYP2B6, CYP2C9, and CYP2D6 2
  • Bupropion is metabolized by these same enzyme systems, creating potential for pharmacokinetic interactions 2

Clinical Effects of Concurrent Use

  • There is no evidence that bupropion decreases the psychoactive or physiological effects of THC 1, 4
  • Some research suggests that cannabinoids may actually enhance the effects of certain medications, including analgesics 5
  • Bupropion's antagonism of nicotinic receptors may theoretically interact with cannabis effects, but this has not been shown to reduce THC's psychoactive properties 3

Potential Risks and Considerations

  • Both bupropion and cannabis can independently affect cardiovascular function:
    • Cannabis use is associated with tachycardia and potential orthostatic hypotension 1
    • Bupropion should be avoided in patients with uncontrolled hypertension 1
  • Bupropion may lower the seizure threshold, with seizure risk of approximately 1 in 1000 1, 6
    • This risk may be heightened with higher doses of bupropion 6
    • Cannabis has complex effects on seizure threshold that vary by cannabinoid composition 1
  • Both substances can affect mood and cognition:
    • Bupropion is FDA-approved as an antidepressant 1
    • THC can have variable effects on mood and cognition depending on dose, chronicity of use, and individual factors 1

Practical Management Considerations

  • Wellbutrin XL 300mg is typically administered as a once-daily dose in the morning 7
  • For patients using both substances:
    • Monitor for increased heart rate and blood pressure 1
    • Be aware of potential increased risk of adverse effects, particularly with higher doses of either substance 6
    • Consider the possibility of enhanced THC effects due to metabolic interactions 2
  • If discontinuing either substance:
    • Abrupt cessation of bupropion may lead to withdrawal symptoms 7
    • Cannabis cessation may lead to withdrawal symptoms that bupropion has not been proven to effectively treat 4

Special Clinical Considerations

  • Bupropion is contraindicated in patients with seizure disorders due to its ability to lower seizure threshold 1, 7
  • In patients with moderate to severe hepatic impairment, the total daily dose of bupropion should not exceed 150mg daily 1, 7
  • In patients with moderate to severe renal impairment, the total daily dose should be reduced by half 1, 7

In conclusion, there is no evidence that Wellbutrin XL 300mg decreases the effects of THC. Instead, clinicians should be aware of potential pharmacokinetic interactions that could potentially enhance THC effects and monitor for adverse cardiovascular and neurological effects when these substances are used concurrently.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacotherapies for cannabis dependence.

The Cochrane database of systematic reviews, 2019

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.